Medullary Carcinoma and Thyrocalcitonin
Overview
Affiliations
Seven patients with medullary carcinoma of the thyroid were investigated, and the thyrocalcitonin activity of the primary tumours, metastatic deposits, and the serum was estimated.Medullary carcinomas of the thyroid with amyloid stroma contain 100 to 600 times more thyrocalcitonin than normal thyroid tissue, and lymph nodes with metastatic deposits are equally rich in the hormone. High values of thyrocalcitonin are also found in the blood of these patients. Medullary carcinoma of the thyroid with amyloid stroma is the first disease to be recognized in which there is hypersecretion of thyrocalcitonin.
Bussolati G Endocr Pathol. 2014; 25(2):133-40.
PMID: 24756777 DOI: 10.1007/s12022-014-9311-1.
Improvement of radioimmunotherapy using pretargeting.
Frampas E, Rousseau C, Bodet-Milin C, Barbet J, Chatal J, Kraeber-Bodere F Front Oncol. 2013; 3:159.
PMID: 23802097 PMC: 3687199. DOI: 10.3389/fonc.2013.00159.
Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).
Kraeber-Bodere F, Salaun P, Ansquer C, Drui D, Mirallie E, Faivre-Chauvet A Tumour Biol. 2012; 33(3):601-6.
PMID: 22396039 DOI: 10.1007/s13277-012-0359-6.
Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer.
Kraeber-Bodere F, Goldenberg D, Chatal J, Barbet J Curr Oncol. 2009; 16(5):3-8.
PMID: 19862356 PMC: 2768511. DOI: 10.3747/co.v16i5.464.
Chronic diarrhoea--all in the bowel?.
Gupta S, Tibbs C, Farthing M, Pollok R J R Soc Med. 2007; 100(8):379-81.
PMID: 17682032 PMC: 1939953. DOI: 10.1177/014107680710000815.